SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Companies develop pediatric medical devices to compete for $50,000 prize Will the smallest of patients finally have more options?

New imaging method may detect cancer earlier Will shortwave infrared be a bright spot?

Siemens AAMI 2014 CMS debate video released See a video of the debate on CMS's imaging equipment maintenance edict from December 2013

Technology uses extremely cold temperatures to treat breast cancer Multi-center trial enrolls first patients

Samsung's tablet ultrasound can diagnose patients en route to hospital The technology can prove crucial when seconds matter

Ultrasound-powered chip monitors diseases and delivers therapies May be able to study nervous system and treat Parkinson's symptoms

Celgene invests in Sequenta's MRD test Test will participate in trials to create blood cancer medicine

AFT calls for improved Ebola hospital protocols Meanwhile, 43 people in Texas are removed from Ebola watch list

Americans with insurance still not going to doctor Will making cost and quality information transparent be the solution?

Mass. health care cost transparency law underperforming Pricing still murky after transparency law introduced

After testicular cancer, follow-up CT scans don't up tumor risk

by Brendon Nafziger , DOTmed News Associate Editor
Follow-up CT scans for men previously diagnosed with testicular cancer don't appear to up the risk for new tumors, according to a new study.

The study, published Monday online ahead of print in the Journal of Clinical Oncology, tracked thousands of patients, some for nearly a decade.

Story Continues Below Advertisement

Delivering on Dose Reduction Promises

Dr. Steven Mendelsohn of Zwanger-Pesiri Radiology, explains his commitment to dose reduction and why he believes a change in attitudes will be driven by patients rather than radiology professionals. Click to read more>>>



Men previously treated for low-grade testicular cancer often have abdominal-pelvic CT scans to monitor for recurring disease. But doctors have long wondered if the ionizing radiation delivered from the scans affect patients' future cancer risk.

Yet in their recent study, a group of Canadian scientists say the scans appear to be safe.

"Second malignancies of the abdomen-pelvis are uncommon in men with low-grade testicular cancer," wrote the researchers, led by Dr. Carl van Walraven of the University of Ottawa. "In this study, the risk of second cancer was not associated with the amount of diagnostic radiation exposure."

The researchers said they used population-based datasets to find every testicular cancer patient in Ontario from 1991 to 2004, excluding only those who had radiation therapy, a previous cancer, retroperitoneal lymph node dissection or were under observation for less than 5 years. Radiation therapy, which uses much higher doses of radiation than CT scans, is linked with cancer recurrence.

The remaining 2,569 men (average age: 35) were observed for a median 11 years -- in general, until the end of 2009, or until they developed a second abdominal-pelvic cancer or died.

These men underwent a median 10 CT scans within the first 5 years of testicular cancer diagnosis, receiving a median radiation exposure of 110 mSv from the scans. Nonetheless, the scans weren't linked with developing a secondary malignancy.

About 14 men -- for a rate of five per 10,000 patients-years of observation -- developed a second tumor, the researchers said, most commonly a colorectal or kidney malignancy.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED